Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study
Keyword(s):
2019 ◽
Vol 10
(1)
◽
pp. 143-148
◽
Keyword(s):
2019 ◽
Vol 4
(5)
◽
pp. 376-388
◽